Patients First Act of 2017 (HR 2918, 115th Congress)
Promotes and facilitates stem cell research showing evidence of substantial clinical benefit to patients, while placing restrictions on the creation, injury, and destruction of embryos for such research.
Houston Chronicle – A Houston-led team of ethicists is touting lawsuits as a way to fight the proliferation of for-profit stem-cell clinics, increasingly luring patients desperate for new treatment for their conditions.
The Sacramento Bee - The California stem cell agency on Wednesday completed creation of a $30 million effort to dramatically speed approval of stem cell therapies and establish the Golden State globally in the much-heralded regenerative medicine field.
MIT Technology Review – No field of biotechnology has promised more and delivered less in the way of treatments than embryonic stem cells. Only a handful of human studies has ever been carried out, without significant results.